SatRx LLC
🇷🇺Russia
- Country
- 🇷🇺Russia
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.satrx.ru
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- SatRx LLC
- Target Recruit Count
- 299
- Registration Number
- NCT03088670
- Locations
- 🇷🇺
Non-state healthcare Organization "Road Clinical Hospital at the station Chelyabinsk Open Joint Stock Company" Russian Railways, Chelyabinsk, Russian Federation
🇷🇺State Budget Healthcare Institution of Moscow "Endocrinology Dispensary", Moscow, Russian Federation
🇷🇺SEI HPE "First Moscow State Medical University n.a. I.M. Sechenov of Ministry of Health and Social Development of the Russian Federation", Chair of faculty therapy #2 based at SHI of Moscow "City clinical hospital #61", Moscow, Russian Federation
News
No news found